Skip to main content
    1

    10X Genomics Inc (TXG)

    Official site

    HEALTHCARE • HEALTH INFORMATION SERVICES • NASDAQ

    $54.99
    -3.20 (-5.50%)

    Market Cap: $7.65B

    Last updated: Nov 17, 2026 at 11:06 AM ET

    10X Genomics Inc (TXG) Government Contracts

    Updated Aug 4, 2026. Contract data from federal award records.

    Federal agencies obligated $6.69M to 10X Genomics over the 12 months through Jul 31, 2026, down 29.1% from the prior 12 months. Department of Health and Human Services was the top awarding agency with 77.2% of obligations across 4 agencies. 10X Genomics had obligation activity on 99 federal contracts over the same 12 months, including 88 new contracts.

    Federal Obligations

    Federal contract obligations are bookings recorded by the awarding agency, not recognized revenue. They can exceed 100% of revenue and can be negative when contracts are de-obligated.

    Obligations
    $6.69M
    Change
    -29.1%
    Obligations to revenue
    1.0%
    Prior 12 months$9.43M
    Contracts with activity99
    New contracts88
    Top agencyDepartment of Health and Human Services
    Top agency share77.2%
    Agencies4
    Average remaining term7.5 months

    12 months through Jul 31, 2026

    Largest New Awards

    The 10 largest new awards total $2.63M, and the largest makes up 13.3% of that.

    Award IDAgencyAmountStartEndDescription
    36C24126P0349Department of Veterans Affairs, Department of Veterans Affairs$349,999Jun 15, 2026Jun 14, 202710X GENOMICS TEST KITS
    36C24225P1431Department of Veterans Affairs, Department of Veterans Affairs$334,143Sep 10, 2025Sep 9, 2028GENE EXPRESSION REAGENTS
    75N95D25F40047Department of Health and Human Services, National Institutes of Health$249,991Sep 25, 2025Oct 24, 2025BIOLOGICAL REAGENT MATERIAL - CHROMIUM NEXT GEM SINGLE CELL MULTIOME AND GEM-X SINGLE CELL 5 KITS AND RELATED INDEXES AND CHIPS.
    75N93025P01086Department of Health and Human Services, National Institutes of Health$249,964Sep 29, 2025Sep 28, 2026REAGENTS FOR ONGOING NGS PROJECTS (AMBIS 2270566)
    75N95D25F40028Department of Health and Human Services, National Institutes of Health$249,934Aug 18, 2025Nov 17, 2025IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING - KITS AND REAGENTS USED IN SINGLE-CELL AND GENE PANEL ANALYSES
    75N95D25F40044Department of Health and Human Services, National Institutes of Health$249,785Sep 24, 2025Oct 24, 2025IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING - GEM-X UNIVERSAL GENE EXPRESSION AND CHROMIUM GEM-X SINGLE CELL CHIPS
    75N95D25F40021Department of Health and Human Services, National Institutes of Health$247,506Aug 1, 2025Oct 31, 2025BIOLOGICAL AND REAGENT MATERIAL - GEM-X FLEX GENE EXPRESSION AND SAMPLE PREP/DUAL INDEX KITS
    75N95D25F40045Department of Health and Human Services, National Institutes of Health$246,535Sep 25, 2025Dec 24, 2025IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING - GEM-X UNIVERSAL GENE EXPRESSION AND GEM-X SINGLE CELL CHIP KITS
    75N95D25F40029Department of Health and Human Services, National Institutes of Health$243,284Aug 18, 2025Nov 17, 2025IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING - VISIUM HD, HUMAN TRANSCRIPTOME 6.5 MM, 16 RXNS AND DUAL INDEX KIT TS SET A, 96 RXN.
    75N95D25F40035Department of Health and Human Services, National Institutes of Health$208,360Sep 19, 2025Oct 3, 2025BIOLOGICAL AND REAGENT MATERIAL - CHROMIUM GEM-X CONSUMABLES.
    New federal contracts awarded in the 12 months through Jul 31, 2026, largest first.

    Monthly Obligations

    The latest complete month, Apr 2026, had $39,953 in obligations. The largest month in the table was Sep 2025, at $3.46M, the last month of the federal fiscal year.

    MonthObligations
    Jul 2026$116,355
    Jun 2026$440,899
    May 2026$60,997
    Apr 2026$39,953
    Mar 2026-$0
    Feb 2026$83,025
    Jan 2026$55,814
    Dec 2025$480,172
    Nov 2025$0
    Oct 2025$0
    Sep 2025$3.46M
    Aug 2025$1.95M
    MonthObligations
    Jul 2025$1.16M
    Jun 2025$1.05M
    May 2025$635,322
    Apr 2025$195,394
    Mar 2025$162,763
    Feb 2025$859,149
    Jan 2025$186,295
    Dec 2024$551,720
    Nov 2024$128,175
    Oct 2024$395,589
    Sep 2024$1.70M
    Aug 2024$2.41M

    Net obligations recorded each month, newest first. Agencies report contract actions with a delay (the Defense Department about 90 days), so the latest months, May to Jul 2026, are still incomplete and the 12-month total usually rises as agencies report the rest.

    Frequently Asked Questions About TXG

    How much does 10X Genomics receive in federal contracts?

    10X Genomics had $6.69M in federal contract obligations over the 12 months through Jul 31, 2026, compared with $9.43M in the 12 months before, down 29.1%. Obligations are contract bookings by the awarding agency, not recognized revenue.

    What are 10X Genomics' largest government contracts?

    The largest new awards over the 12 months through Jul 31, 2026 were 36C24126P0349, Department of Veterans Affairs, $349,999, started Jun 15, 2026; 36C24225P1431, Department of Veterans Affairs, $334,143, started Sep 10, 2025; 75N95D25F40047, Department of Health and Human Services, $249,991, started Sep 25, 2025.

    Which agencies award 10X Genomics contracts?

    Department of Health and Human Services was the top awarding agency with 77.2% of obligations over the 12 months through Jul 31, 2026. The records cover 4 agencies. Other agencies in the awards list include Department of Veterans Affairs.

    What new federal contracts did 10X Genomics win in the 12 months through Jul 31, 2026?

    10X Genomics won 88 new federal contracts in the 12 months through Jul 31, 2026. The largest was 36C24126P0349, Department of Veterans Affairs, $349,999, started Jun 15, 2026.

    How do 10X Genomics' federal obligations compare with its revenue?

    Federal contract obligations were $6.69M over the 12 months through Jul 31, 2026, equivalent to 1.0% of 10X Genomics' revenue. Obligations are amounts the government committed to contracts in the period, not the share of 10X Genomics' revenue that comes from the government.